Removing Barriers. Expanding Capacity. How Source BioScience Built a Scalable Digital Pathology Network with HALO AP®
Read How Source BioScience Built a Scalable Digital Pathology Network with HALO AP®. Supporting over 90 NHS Trusts.
Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership
ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration modernizes NeoGenomics enterprise digital pathology infrastructure, accelerates AI adoption across clinical operations and biomarker analysis, and establishes a joint development framework for the next generation of companion diagnostic (CDx) solutions.
Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation
Roslyn Heights, NY and Albuquerque, NM, September 22, 2026 – Voicebrook, the leader in pathology workflow automation, driving reporting end to end, today announced a new integration partnership with Indica Labs, the trusted global leader in AI-powered digital pathology . The integration connects Voicebrook’s VoiceOver PRO reporting workflow to the Indica Labs HALO AP platform, giving pathologists hands-free control of digital slide review while allowing HALO Clinical AI-generated biomarker results to flow automatically into the appropriate CAP cancer protocol checklist.
Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom
Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.
Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis
Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), and areas of benign tissue prior to biomarker analysis. This zero-click preprocessing and tissue classification workflow represents a critical step in ensuring accurate and reproducible AI outputs.
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI Read More »
HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability
Albuquerque, NM, July 14, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency.
Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification
Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue specimens. Prostate Macrodissect AI is designed to operate in concert with Indica Labs’ broader HALO Clinical AI suite, enabling laboratories to build end-to-end AI-powered prostate cancer workflows from automated tumor detection and Gleason grading assistance through to optimized macrodissection and genomic test preparation within a single, validated digital pathology platform.
Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx
HALO AP 2.5 introduces Lab Logic. A configuration layer that enables labs to tailor HALO AP® to their preferred workflow, enabling any lab, regardless of case volume, to operate like an automated triage engine, continuously analyzing incoming slides; triggering AI-driven actions; and delivering the right cases to the right experts at the right time.
Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx Read More »
Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers
VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a leading provider of AI solutions for cancer diagnostics and therapeutics, to develop AI-powered image analysis algorithms. The partnership will focus on PD-L1 and emerging immunohistochemistry (IHC) biomarkers, supporting scalable and consistent biomarker quantification through computational pathology tools. The first product is an AI-powered Lunit SCOPE algorithm designed for Leica Biosystems’ PD-L1 primary antibody (CAL10). The new algorithm, Lunit SCOPE PD-L1 CAL10 NSCLC1, is now available through Leica Biosystems’ Aperio AI Store.